NCT04167566View on ClinicalTrials.gov

Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among Children

NACompletedINTERVENTIONAL
Enrollment

5,000

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

July 30, 2019

Study Completion Date

July 30, 2019

Conditions
MalariaMalaria, Asymptomatic Parasitaemia
Interventions
COMBINATION_PRODUCT

Artemisinin Combination Therapy ACTs

All participants will be tested using RDTs and all confirmed cases will be treated with ACTs. The ACT regimen use at each time will be the one the National Malaria Control Programme will be using at that particular moment.

Trial Locations (1)

+233

Noguchi Memorial Institute for Medical Research, Accra

All Listed Sponsors
collaborator

World Health Organization

OTHER

lead

Noguchi Memorial Institute for Medical Research

OTHER

NCT04167566 - Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among Children | Biotech Hunter | Biotech Hunter